S100A9 and hepatocellular carcinoma: Indeed, tumor cell proliferation in S100A9 genetically deficient mice was unaffected in an Mdr2−/− inflammation-driven HCC mouse model [159], whereas tumor cell proliferation was decreased in a DEN-induced HCC model developing in the absence of chronic inflammation [44].